Literature DB >> 18513372

Expression of E-FABP in PC12 cells increases neurite extension during differentiation: involvement of n-3 and n-6 fatty acids.

Jo-Wen Liu1, Frankis G Almaguel, Liming Bu, Daisy D De Leon, Marino De Leon.   

Abstract

Epidermal fatty acid-binding protein (E-FABP), a member of the family of FABPs, exhibits a robust expression in neurons during axonal growth in development and in nerve regeneration following nerve injury. This study examines the impact of E-FABP expression in normal neurite extension in differentiating pheochromocytoma cell (PC12) cultures supplemented with selected long chain free fatty acids (LCFFA). We found that E-FABP binds to a broad range of saturated and unsaturated LCFFAs, including those with potential interest for neuronal differentiation and axonal growth such as C22:6n-3 docosahexaenoic acid (DHA), C20:5n-3 eicosapentaenoic acid (EPA), and C20:4n-6 arachidonic acid (ARA). PC12 cells exposed to nerve growth factor (NGFDPC12) exhibit high E-FABP expression that is blocked by mitogen-activated protein kinase kinase (MEK) inhibitor U0126. Nerve growth factor-differentiated pheochromocytoma cells (NGFDPC12) antisense clones (NGFDPC12-AS) which exhibit low E-FABP expression have fewer/shorter neurites than cells transfected with vector only or NGFDPC12 sense cells (NGFDPC12-S). Replenishing NGFDPC12-AS cells with biotinylated recombinant E-FABP (biotin-E-FABP) protein restores normal neurite outgrowth. Cellular localization of biotin-E-FABP in NGFDPC12 was detected mostly in the cytoplasm and in the nuclear region. Treatment of NGFDPC12 with DHA, EPA, or ARA further enhances neurite length but it does not trigger further induction of TrkA or MEK phosphorylation or E-FABP mRNA observed in differentiating PC12 cells without LCFFA supplementation. Significantly, DHA and EPA neurite stimulating effects are higher in NGFDPC12-S than in NGFDPC12-AS cells. These findings are consistent with the scenario that neurite extension of differentiating PC12 cells, including further stimulation by DHA and EPA, requires sufficient cellular levels of E-FABP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18513372      PMCID: PMC2785489          DOI: 10.1111/j.1471-4159.2008.05507.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  73 in total

Review 1.  The biochemistry of n-3 polyunsaturated fatty acids.

Authors:  Donald B Jump
Journal:  J Biol Chem       Date:  2001-12-17       Impact factor: 5.157

2.  (n-3) polyunsaturated fatty acid deficiency reduces the expression of both isoforms of the brain glucose transporter GLUT1 in rats.

Authors:  Fabien Pifferi; Françoise Roux; Bénédicte Langelier; Jean-Marc Alessandri; Sylvie Vancassel; Mélanie Jouin; Monique Lavialle; Philippe Guesnet
Journal:  J Nutr       Date:  2005-09       Impact factor: 4.798

3.  A decrease in cell size accompanies a loss of docosahexaenoate in the rat hippocampus.

Authors:  Aneeq Ahmad; Mahadev Murthy; Rebecca S Greiner; Toru Moriguchi; Norman Salem
Journal:  Nutr Neurosci       Date:  2002-04       Impact factor: 4.994

4.  Induction and axonal localization of epithelial/epidermal fatty acid-binding protein in retinal ganglion cells are associated with axon development and regeneration.

Authors:  G W Allen; J Liu; M A Kirby; M De León
Journal:  J Neurosci Res       Date:  2001-11-01       Impact factor: 4.164

5.  The pH-dependent unfolding mechanism of P2 myelin protein: an experimental and computational study.

Authors:  Eugenia Polverini; Micaela Fornabaio; Anna Fasano; Giulia Carlone; Paolo Riccio; Paolo Cavatorta
Journal:  J Struct Biol       Date:  2005-12-27       Impact factor: 2.867

Review 6.  The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism.

Authors:  Agata Chmurzyńska
Journal:  J Appl Genet       Date:  2006       Impact factor: 3.240

7.  Solution structure and backbone dynamics of human epidermal-type fatty acid-binding protein (E-FABP).

Authors:  Luis H Gutiérrez-González; Christian Ludwig; Carsten Hohoff; Martin Rademacher; Thorsten Hanhoff; Heinz Rüterjans; Friedrich Spener; Christian Lücke
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

8.  Activation of p38 mitogen-activated protein kinase and activator protein-1 during the promotion of neurite extension of PC-12 cells by 15-deoxy-delta12,14-prostaglandin J2.

Authors:  Kyung Mi Jung; Ki Sook Park; Jae Ho Oh; Soo Youn Jung; Ki Hwa Yang; Youn Sook Song; Dong Ju Son; Young Hyun Park; Yeo Pyo Yun; Myung Koo Lee; Ki Wan Oh; Jin Tae Hong
Journal:  Mol Pharmacol       Date:  2003-03       Impact factor: 4.436

Review 9.  New insights into the structure and function of fatty acid-binding proteins.

Authors:  A W Zimmerman; J H Veerkamp
Journal:  Cell Mol Life Sci       Date:  2002-07       Impact factor: 9.261

10.  Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription.

Authors:  Nguan-Soon Tan; Natacha S Shaw; Nicolas Vinckenbosch; Peng Liu; Rubina Yasmin; Béatrice Desvergne; Walter Wahli; Noa Noy
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

View more
  25 in total

1.  Polymorphisms in fatty acid binding protein 5 show association with type 2 diabetes.

Authors:  Liming Bu; Lorena M Salto; Kevin J De Leon; Marino De Leon
Journal:  Diabetes Res Clin Pract       Date:  2011-02-01       Impact factor: 5.602

2.  Ligand Bound Fatty Acid Binding Protein 7 (FABP7) Drives Melanoma Cell Proliferation Via Modulation of Wnt/β-Catenin Signaling.

Authors:  Banlanjo Abdulaziz Umaru; Yoshiteru Kagawa; Subrata Kumar Shil; Naoki Arakawa; Yijun Pan; Hirofumi Miyazaki; Shuhei Kobayashi; Shuhan Yang; An Cheng; Yifei Wang; Yasuharu Shinoda; Yukiko Kiniwa; Ryuhei Okuyama; Kohji Fukunaga; Yuji Owada
Journal:  Pharm Res       Date:  2021-03-01       Impact factor: 4.200

3.  Fatty Acid Binding Protein 5 Modulates Docosahexaenoic Acid-Induced Recovery in Rats Undergoing Spinal Cord Injury.

Authors:  Johnny D Figueroa; Miguel Serrano-Illan; Jenniffer Licero; Kathia Cordero; Jorge D Miranda; Marino De Leon
Journal:  J Neurotrauma       Date:  2016-03-29       Impact factor: 5.269

4.  Brain fatty acid-binding protein and omega-3/omega-6 fatty acids: mechanistic insight into malignant glioma cell migration.

Authors:  Raja Mita; Michael J Beaulieu; Catherine Field; Roseline Godbout
Journal:  J Biol Chem       Date:  2010-09-12       Impact factor: 5.157

5.  Docosahexaenoic acid pretreatment confers protection and functional improvements after acute spinal cord injury in adult rats.

Authors:  Johnny D Figueroa; Kathia Cordero; Keisha Baldeosingh; Aranza I Torrado; Robert L Walker; Jorge D Miranda; Marino De Leon
Journal:  J Neurotrauma       Date:  2011-11-07       Impact factor: 5.269

6.  Hyperglycemia magnifies Schwann cell dysfunction and cell death triggered by PA-induced lipotoxicity.

Authors:  Amelia Padilla; Magda Descorbeth; Audra L Almeyda; Kimberly Payne; Marino De Leon
Journal:  Brain Res       Date:  2010-11-23       Impact factor: 3.252

Review 7.  Tissue-specific functions in the fatty acid-binding protein family.

Authors:  Judith Storch; Alfred E Thumser
Journal:  J Biol Chem       Date:  2010-08-17       Impact factor: 5.157

8.  Using evolutionary conserved modules in gene networks as a strategy to leverage high throughput gene expression queries.

Authors:  Jeanne M Serb; Megan C Orr; M Heather West Greenlee
Journal:  PLoS One       Date:  2010-09-02       Impact factor: 3.240

9.  Fatty Acid Binding Proteins Expressed at the Human Blood-Brain Barrier Bind Drugs in an Isoform-Specific Manner.

Authors:  Gordon S Lee; Katharina Kappler; Christopher J H Porter; Martin J Scanlon; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2015-08-07       Impact factor: 4.200

10.  Differential transcriptional modulation of duplicated fatty acid-binding protein genes by dietary fatty acids in zebrafish (Danio rerio): evidence for subfunctionalization or neofunctionalization of duplicated genes.

Authors:  Santhosh Karanth; Santosh P Lall; Eileen M Denovan-Wright; Jonathan M Wright
Journal:  BMC Evol Biol       Date:  2009-09-02       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.